Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation

European Journal of Cardio-thoracic Surgery

Volumn 34, Issue 3, 2008, Pages 685-686

  Chalwin, Richard P ^a   Tiruvoipati, Ravindranath ^a   Peek, Giles J ^a  

^a GLENFIELD HOSPITAL   (United Kingdom)

Author keywords

Bleeding; Extracorporeal membrane oxygenation; Thrombosis

Indexed keywords

APROTININ; NITRIC OXIDE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; SURFACTANT;

AORTA ARCH; ARTICLE; BLEEDING; CASE REPORT; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; FEMALE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART OUTPUT; HIGH FREQUENCY VENTILATION; HUMAN; MITRAL VALVE REPLACEMENT; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; PRIORITY JOURNAL; ST SEGMENT; THROMBOSIS;

COAGULANTS; EXTRACORPOREAL MEMBRANE OXYGENATION; FACTOR VIIA; FATAL OUTCOME; FEMALE; HUMANS; INFANT; RECOMBINANT PROTEINS; THROMBOSIS;

EID: 49149132047     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.05.022     Document Type: Article

References (8)

1. Dominguez T.E., Mitchell M., Friess S.H., Huh J.W., Manno C.S., Ravishankar C., Gaynor J.W., and Tabbutt S. Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation. Pediatr Crit Care Med 6 (2005) 348-351
2. Wittenstein B., Ng C., Ravn H., and Goldman A. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery. Pediatr Crit Care Med 6 (2005) 473-476
3. Levi M., Peters M., and Buller H.R. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review. Crit Care Med 33 (2005) 883-890
4. Roberts H.R., Monroe III D.M., and Hoffman M. Safety profile of recombinant factor VIIa. Semin Hematol 41 (2004) 101-108
5. Steiner M.E., Key N.S., and Levy J.H. Activated recombinant factor VII in cardiac surgery. Curr Opin Anaesthesiol 18 (2005) 89-92
6. Al Douri M., Shafi T., Al Khudairi D., Al Bokhari E., Black L., Akinwale N., Osman M.M., Al Homaidhi A., Al Fagih M., and Borum A.R. Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery. Blood Coagul Fibrinolysis 11 (2000) S121-S127
7. Tanos M., and Dunning J. Is recombinant activated factor VII useful for intractable bleeding after cardiac surgery?. Interact Cardiovasc Thorac Surg 5 (2006) 493-498
8. Schmid S., Friesenecker B., Lorenz I., Innerhofer P., Koscielny J., Velik-Salchner C., Mutz N., and Fries D. Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy. Clin Appl Thromb Hemost 13 (2007) 313-317